富国集团维持GE HealthCare Technologies(GEHC.US)买入评级,维持目标价96美元 富国集团分析师Larry Biegelsen维持$GE HealthCare Technologies(GEHC.US)$买入评级,维持目标价96美元。根据TipRanks数据显示,该分析师近一年总胜率为63.2%,总平均回报率为11.4%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,并计...
GE HealthCare Technologies所有资讯 新闻 公告 评级 GE医疗2024财年第三财季实现净利润4.71亿美元,同比增加24.27% 市场透视00:00 一图速览GE HealthCare Technologies(GEHC.US)今日评级,最高看至102美元 美东时间11月1日,多家华尔街大行更新了$GE HealthCare Technologies(GEHC.US)$的评级,目标价介于97美元至102...
Current Price $205.86 NYSE: DOCS Doximity Market Cap $8B Current Price $43.88 NASDAQ: MASI Masimo Market Cap $7B Current Price $134.89 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. ...
Recent News HealthcareGE HealthCare Guidance Was Good. The Stock Dropped Anyway. Nov. 21, 2024 at 4:26 p.m. ETby Barron's GE HealthCare Raises Quarterly Dividend by 17% Nov. 21, 2024 at 7:22 a.m. ET GE HealthCare Gets FDA Approval For Head-Only MRI Scanner ...
智通财经获悉,GEHealthCare已同意从SumitomoChemical手中收购NihonMedi-Physics剩余50%的股份,旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。NMP的产品组合包括GEHealthCare放射药物,用于神经病学、心脏病学和肿瘤学手术的临床成像 ...
Get GE Healthcare Technologies Inc (GEHC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
GE HealthCare to begin trading on The Nasdaq Stock Market LLC (“Nasdaq”) on January 4, 2023, under ticker “GEHC”; GE will continue to trade on New York Stock Exchange (“NYSE”) under ticker “GE” GE remains on track to launch GE Aerospace and GE Vernova[1]as independent, indus...
GE Healthcare’s stock spikes up at the open as profit beat outweighs sales miss Jul. 31, 2024 at 10:38 a.m. ET by Tomi Kilgore Technology GE HealthCare’s Stock Is Rising After Earnings Beat Jul. 31, 2024 at 10:18 a.m. ET by Barron's Other News Press Releases GE Heal...
Find the latest GE Healthcare Technologies, GEHC stock market data. Get a full understanding of how GE Healthcare Technologies is performing with stock quotes and prices, as well as real-time news and analy
Get GE HealthCare Technologies alerts: Insiders Place Their Bets In other news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the ...